| Primary |
| Lymphoma |
13.2% |
| Small Cell Lung Cancer Stage Unspecified |
10.5% |
| Acute Lymphocytic Leukaemia |
8.6% |
| Lung Neoplasm Malignant |
7.2% |
| Testis Cancer |
7.2% |
| Histiocytosis Haematophagic |
6.2% |
| Non-hodgkin's Lymphoma |
5.7% |
| Acute Myeloid Leukaemia |
4.3% |
| Rhabdomyosarcoma |
4.3% |
| Nongerminomatous Germ Cell Tumour Of The Cns |
3.8% |
| Adult T-cell Lymphoma/leukaemia |
3.3% |
| Hepatoblastoma |
3.1% |
| Hodgkin's Disease |
3.1% |
| Medulloblastoma |
3.1% |
| T-cell Lymphoma |
3.1% |
| Diffuse Large B-cell Lymphoma |
2.9% |
| Prostate Cancer |
2.9% |
| Retinoblastoma Bilateral |
2.6% |
| Choriocarcinoma |
2.4% |
| Ewing's Sarcoma |
2.4% |
|
| Pneumonitis |
10.3% |
| White Blood Cell Count Decreased |
10.3% |
| Interstitial Lung Disease |
8.6% |
| Death |
7.8% |
| Vomiting |
7.8% |
| Treatment Related Secondary Malignancy |
6.9% |
| Neutropenia |
5.2% |
| Malignant Neoplasm Progression |
4.3% |
| Respiratory Failure |
4.3% |
| Leukopenia |
3.4% |
| Myelodysplastic Syndrome |
3.4% |
| Pneumonia |
3.4% |
| Pregnancy |
3.4% |
| Sepsis |
3.4% |
| Stomatitis |
3.4% |
| Tumour Lysis Syndrome |
3.4% |
| Deep Vein Thrombosis |
2.6% |
| Leiomyosarcoma |
2.6% |
| Lymphoproliferative Disorder |
2.6% |
| Multi-organ Failure |
2.6% |
|
| Secondary |
| Stem Cell Transplant |
13.1% |
| Non-hodgkin's Lymphoma |
12.0% |
| Drug Use For Unknown Indication |
11.1% |
| Hodgkin's Disease |
8.1% |
| Product Used For Unknown Indication |
6.4% |
| Small Cell Lung Cancer Stage Unspecified |
5.4% |
| Acute Lymphocytic Leukaemia |
5.3% |
| Lymphoma |
5.1% |
| Neoplasm Malignant |
4.8% |
| Burkitt's Lymphoma |
4.2% |
| Prophylaxis |
3.7% |
| Diffuse Large B-cell Lymphoma |
3.1% |
| Bone Sarcoma |
3.1% |
| Testis Cancer |
2.9% |
| Ovarian Cancer |
2.5% |
| Multiple Myeloma |
2.1% |
| Adult T-cell Lymphoma/leukaemia |
1.8% |
| Testicular Mass |
1.8% |
| B-cell Lymphoma |
1.7% |
| Premedication |
1.7% |
|
| White Blood Cell Count Decreased |
11.4% |
| Interstitial Lung Disease |
9.7% |
| Tremor |
7.4% |
| Febrile Neutropenia |
6.3% |
| Acute Myeloid Leukaemia |
5.7% |
| Pupils Unequal |
5.7% |
| Pyrexia |
5.1% |
| Sepsis |
5.1% |
| Thrombocytopenia |
5.1% |
| Pancytopenia |
4.6% |
| Stomatitis |
4.6% |
| Myelodysplastic Syndrome |
4.0% |
| Pulmonary Embolism |
4.0% |
| Agranulocytosis |
3.4% |
| Vomiting |
3.4% |
| C-reactive Protein Increased |
2.9% |
| Nervous System Disorder |
2.9% |
| Neutropenia |
2.9% |
| Septic Shock |
2.9% |
| Thrombotic Microangiopathy |
2.9% |
|
| Concomitant |
| Neoplasm Malignant |
35.6% |
| Stem Cell Transplant |
10.1% |
| Acute Lymphocytic Leukaemia |
8.3% |
| Prophylaxis |
8.1% |
| T-cell Type Acute Leukaemia |
7.4% |
| Diffuse Large B-cell Lymphoma |
3.4% |
| Infection Prophylaxis |
3.3% |
| Small Cell Lung Cancer Stage Unspecified |
3.3% |
| Hypertension |
3.1% |
| Product Used For Unknown Indication |
2.0% |
| Cord Blood Transplant Therapy |
1.8% |
| Febrile Neutropenia |
1.8% |
| Primitive Neuroectodermal Tumour |
1.8% |
| Drug Use For Unknown Indication |
1.6% |
| Prophylaxis Of Nausea And Vomiting |
1.6% |
| Bone Sarcoma |
1.4% |
| Mycosis Fungoides |
1.4% |
| Chemotherapy |
1.3% |
| Constipation |
1.3% |
| Fungal Infection |
1.3% |
|
| White Blood Cell Count Decreased |
13.8% |
| Renal Disorder |
9.2% |
| Renal Impairment |
8.0% |
| Sepsis |
8.0% |
| Vomiting |
6.9% |
| Engraft Failure |
5.7% |
| Pyrexia |
5.7% |
| Inappropriate Antidiuretic Hormone Secretion |
4.6% |
| Small Cell Lung Cancer Stage Unspecified |
4.6% |
| Thrombocytopenia |
4.6% |
| Death |
3.4% |
| Ileus Paralytic |
3.4% |
| Interstitial Lung Disease |
3.4% |
| Pneumonia |
3.4% |
| Renal Tubular Disorder |
3.4% |
| Anaemia Haemolytic Autoimmune |
2.3% |
| Bone Marrow Failure |
2.3% |
| Cardiac Failure |
2.3% |
| Condition Aggravated |
2.3% |
| Deep Vein Thrombosis |
2.3% |
|
